YD
Daali, Youssef
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Application of Microwave-Assisted Method for Lutein Extraction from Pistachio Waste | Journal of nuts | 2024 | 26 | 49 | |||
Guidance on selecting optimal steady-state tacrolimus concentrations for continuous IV perfusion : insights from physiologically based pharmacokinetic modeling | Pharmaceuticals | 2024 | 6 | 2 | |||
Optimization of Lutein Extraction from Pistachio Waste Using Experimental Design and Ultrasonic Method | Waste and biomass valorization | 2024 | 43 | 0 | |||
Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping | Journal of chromatography. B | 2024 | 29 | 23 | |||
Practice of CYP450 genotyping and phenotyping in children in a real-life setting | Frontiers in pharmacology | 2023 | 25 | 8 | |||
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs | Pharmaceutics | 2023 | 26 | 26 | |||
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | 2023 | 77 | 47 | |||
Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail | Basic & clinical pharmacology & toxicology | 2023 | 40 | 0 | |||
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol | Pharmaceuticals | 2023 | 26 | 11 | |||
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT | Transplantation and cellular therapy | 2023 | 31 | 32 | |||
Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approach | Journal of personalized medicine | 2023 | 31 | 6 | |||
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol | Frontiers in pain research | 2023 | 61 | 6 | |||
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | 2023 | 38 | 20 | |||
Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans | Genome biology and evolution | 2022 | 294 | 42 | |||
Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs | Frontiers in pharmacology | 2022 | 133 | 84 | |||
Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response | Pharmaceuticals | 2022 | 49 | 10 | |||
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots | Clinical and translational science | 2022 | 164 | 60 | |||
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | 2022 | 90 | 29 | |||
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | 2022 | 151 | 112 | |||
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity | Frontiers in psychiatry | 2022 | 22 | 29 | |||
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients | Frontiers in aging neuroscience | 2022 | 49 | 9 | |||
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | 2022 | 100 | 99 | |||
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics | CPT: pharmacometrics & systems pharmacology | 2022 | 179 | 231 | |||
Variations in the Frequencies of Polymorphisms in the CYP450s Genes in Eight Major Ethnicities of Iran: A Review of the Human Data | Journal of personalized medicine | 2022 | 19 | 6 | |||
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology & therapeutics | 2022 | 112 | 184 | |||
Personalized Medicine : Pharmacokinetics | Journal of personalized medicine | 2022 | 22 | 3 | |||
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | 2021 | 139 | 57 | |||
Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice | ACS Nano | 2021 | 291 | 418 | |||
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy | Annual Review of Pharmacology and Toxicology | 2021 | 268 | 1 | |||
Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | 2021 | 101 | 0 | |||
Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | 2021 | 227 | 5 | |||
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | 2021 | 195 | 73 | |||
The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker? | Journal of personalized medicine | 2021 | 162 | 32 | |||
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | 2021 | 249 | 100 | |||
The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro | Basic & Clinical Pharmacology & Toxicology | 2021 | 173 | 2 | |||
Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS | Journal of chromatography. B | 2021 | 268 | 252 | |||
Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data | Journal of personalized medicine | 2021 | 129 | 47 | |||
Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | 2021 | 109 | 134 | |||
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study | CPT: pharmacometrics & systems pharmacology | 2021 | 186 | 83 | |||
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | 2020 | 361 | 154 | |||
Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis | British Journal of Clinical Pharmacology | 2020 | 167 | 101 | |||
Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins | Drug Safety | 2020 | 501 | 135 | |||
Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | 2020 | 256 | 289 | |||
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers | European Journal of Pain | 2020 | 204 | 1 | |||
Bioavailability of Vortioxetine After a Roux-en-Y Gastric Bypass | Obesity Surgery | 2020 | 209 | 1 | |||
Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes | Journal of Neuroscience Research | 2020 | 251 | 2 | |||
Modern approaches for the phenotyping of cytochrome P450 enzymes in children | Expert Review of Clinical Pharmacology | 2020 | 155 | 1 | |||
Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children | Therapeutic Drug Monitoring | 2020 | 349 | 130 | |||
Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | 2020 | 209 | 1 | |||
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | 2020 | 297 | 71 | |||
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail | Journal of Personalized Medicine | 2019 | 321 | 151 | |||
Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches | Clinical Pharmacokinetics | 2019 | 333 | 3 | |||
Variables of interest to predict glomerular filtration rate in preterm newborns in the first days of life | Pediatric Nephrology | 2019 | 331 | 1 | |||
Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | 2019 | 405 | 2 | |||
Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanoma | Biochemical and Biophysical Research Communications | 2019 | 310 | 224 | |||
Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic Study | Current Analytical Chemistry | 2019 | 308 | 1 | |||
CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver content | Surgery for Obesity and Related Diseases | 2019 | 301 | 0 | |||
Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | 2019 | 388 | 4 | |||
Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment | Integrative Cancer Therapies | 2019 | 313 | 105 | |||
Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactions | CPT: pharmacometrics & systems pharmacology | 2019 | 331 | 192 | |||
Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled study | European Journal of Pain | 2019 | 322 | 2 | |||
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling | Pediatric Research | 2019 | 263 | 2 | |||
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | 2018 | 566 | 589 | |||
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | 2018 | 438 | 593 | |||
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting | Journal of Clinical Psychiatry | 2018 | 425 | 0 | |||
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software | Biopharmaceutics & Drug Disposition | 2018 | 553 | 12 | |||
Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes | Basic & Clinical Pharmacology & Toxicology | 2018 | 410 | 324 | |||
Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance | Therapeutic Drug Monitoring | 2018 | 775 | 382 | |||
Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case report | European Journal of Anaesthesiology | 2018 | 378 | 229 | |||
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study) | BMC Pharmacology & Toxicology | 2017 | 417 | 154 | |||
Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactions | Clinical Pharmacology and Therapeutics | 2017 | 447 | 5 | |||
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases | Journal of pharmaceutical and biomedical analysis | 2017 | 573 | 527 | |||
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | 2017 | 600 | 152 | |||
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future | Clinical Pharmacology and Therapeutics | 2017 | 505 | 0 | |||
The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | 2017 | 531 | 211 | |||
Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane Transporters | Basic & clinical pharmacology & toxicology | 2017 | 483 | 3 | |||
Plasma concentrations of transdermal fentanyl and buprenorphine in pigs (Sus scrofa domesticus) | Veterinary Anaesthesia and Analgesia | 2017 | 421 | 1 | |||
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine | Journal of Pharmaceutical Sciences | 2017 | 423 | 0 | |||
Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis | Free radical biology & medicine | 2016 | 602 | 243 | |||
An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure | Toxicology and applied pharmacology | 2016 | 560 | 2 | |||
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | 2016 | 418 | 193 | |||
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia | Neuropharmacology | 2016 | 505 | 280 | |||
Detection of busulfan adducts on proteins | RCM. Rapid communications in mass spectrometry | 2016 | 587 | 97 | |||
Aspirin response: Differences in serum thromboxane B2 levels between clinical studies | Platelets | 2016 | 635 | 1 | |||
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | 2016 | 564 | 601 | |||
Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 561 | 0 | |||
Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells | Fundamental & clinical pharmacology | 2016 | 549 | 21 | |||
Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study | Clinical therapeutics | 2016 | 497 | 2 | |||
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method | Basic & clinical pharmacology & toxicology | 2016 | 600 | 360 | |||
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription | Current drug metabolism | 2015 | 535 | 3 | |||
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review | Current drug metabolism | 2015 | 580 | 6 | |||
Augmented renal clearance, low ß-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study | International journal of antimicrobial agents | 2015 | 740 | 3 | |||
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers | Pain | 2015 | 560 | 3 | |||
Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review | Current drug metabolism | 2014 | 605 | 0 | |||
Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping Cocktail | Basic & clinical pharmacology & toxicology | 2014 | 607 | 4 | |||
Phenotyping of CYP450 in human liver microsomes using the cocktail approach | Analytical & bioanalytical chemistry | 2014 | 450 | 2 | |||
Antiplatelet Therapy: Targeting the TxA2 Pathway | Journal of cardiovascular translational research | 2014 | 573 | 2 | |||
Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spots | Clinical pharmacology and therapeutics | 2014 | 809 | 317 | |||
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity | AIDS research and therapy | 2014 | 636 | 908 | |||
The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation | Pharmacogenomics journal | 2014 | 603 | 8 | |||
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model | CPT: pharmacometrics & systems pharmacology | 2014 | 557 | 225 | |||
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma | Bioanalysis | 2014 | 691 | 5 | |||
Role of paraoxonase-1 in CYP2C19 loss-of-function carriers | Thrombosis research | 2014 | 592 | 0 | |||
A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies | Journal of pharmaceutical and biomedical analysis | 2014 | 492 | 7 | |||
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study | Basic & clinical pharmacology & toxicology | 2013 | 592 | 325 | |||
Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties | Arteriosclerosis, thrombosis, and vascular biology | 2013 | 604 | 0 | |||
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | 2013 | 537 | 3 | |||
Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model | The journal of antimicrobial chemotherapy | 2013 | 535 | 0 | |||
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers | Basic & clinical pharmacology & toxicology | 2013 | 574 | 375 | |||
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial | Pain physician | 2013 | 543 | 1 029 | |||
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain | Pain physician | 2013 | 704 | 627 | |||
Applications of CYP450 Testing in the Clinical Setting | Molecular diagnosis & therapy | 2013 | 631 | 771 | |||
Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs | Drug metabolism and disposition | 2013 | 739 | 621 | |||
NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion | Diabetes | 2012 | 722 | 458 | |||
Transcriptional regulation of CYP2C19 and its role in altered enzyme activity | Current drug metabolism | 2012 | 528 | 0 | |||
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient | AIDS | 2012 | 566 | 498 | |||
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers | Chimia | 2012 | 728 | 1 109 | |||
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview | Basic & clinical pharmacology & toxicology | 2012 | 561 | 578 | |||
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2012 | 558 | 0 | |||
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 511 | 0 | |||
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot | Clinical pharmacology and therapeutics | 2012 | 564 | 0 | |||
Analgesics in patients with hepatic impairment: pharmacology and clinical implications | Drugs | 2012 | 643 | 3 | |||
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection | Journal of viral hepatitis | 2012 | 592 | 0 | |||
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry | RCM. Rapid communications in mass spectrometry | 2012 | 746 | 728 | |||
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination | Basic & clinical pharmacology & toxicology | 2011 | 637 | 0 | |||
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients | Metabolism, clinical and experimental | 2011 | 589 | 0 | |||
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain | Neuropharmacology | 2011 | 712 | 548 | |||
How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver | The Journal of pharmacology and experimental therapeutics | 2011 | 551 | 0 | |||
Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite | Journal of pharmaceutical and biomedical analysis | 2011 | 679 | 710 | |||
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone | British journal of pharmacology | 2010 | 677 | 2 | |||
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability | Current drug metabolism | 2010 | 606 | 0 | |||
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety | British journal of pharmacology | 2010 | 545 | 1 | |||
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein | Basic & clinical pharmacology & toxicology | 2009 | 578 | 2 | |||
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study | Journal of chromatography | 2009 | 501 | 0 | |||
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction | Pharmacogenomics journal | 2009 | 775 | 0 | |||
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone | Fundamental & clinical pharmacology | 2009 | 593 | 0 | |||
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers | Drug metabolism letters | 2008 |